That is the most substantial human outcome data currently available for a compound that people are sourcing and injecting based on internet research.[4,5] BPC-157 has been used in Phase II trials for ulcerative colitis and multiple sclerosis.[1,2] Comprehensive published results from those trials are not available in the medical literature
GHK-Cu is a naturally occurring tripeptide
Denys A, Hichami A, Khan NA
Most people tolerate methyl b12 injections very well
Collagen pathway investigations Skin-related signalling studies Regenerative research environments Cellular response modelling Extracellular matrix research Hair and tissue-related research applications GHK-Cu is also frequently explored in laboratory environments investigating tissue-related pathways, oxidative stress models, hair-focused signalling systems, and regenerative cellular interactions
The holes form tunnels in your bone to accept the new graft